5-MAPBT

5-MAPBT
Clinical data
Other namesMY400[1]
ATC code
  • none
Identifiers
  • 1-(1-Benzothiophen-5-yl)-N-methylpropan-2-amine
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC12H15NS
Molar mass205.32 g·mol−1
3D model (JSmol)
  • CC(CC1=CC2=C(C=C1)SC=C2)NC
  • InChI=1S/C12H15NS/c1-9(13-2)7-10-3-4-12-11(8-10)5-6-14-12/h3-6,8-9,13H,7H2,1-2H3
  • Key:SKSFWFUEBKJIAJ-UHFFFAOYSA-N

5-MAPBT (5-methylaminopropylbenzothiophene) is an empathogenic drug closely related to 5-MAPB but with the oxygen atom replaced by sulfur, changing the core ring structure to benzothiophene rather than benzofuran.[2]

See also

References

  1. ^ Mydecine (5 January 2024). "Novel short-acting psychoactive compounds of the mdma class". Google Patents. Retrieved 23 October 2024.
  2. ^ WO 2022/010937, Baggott M, "Advantageous benzothiophene compositions for mental disorders or enhancement.", published 13 January 2022, assigned to Tactogen Inc.